Recent News

ASTRO 2019: Postmastectomy Radiation Therapy for HER2-Positive Breast Cancer

FDA Issues Warning About Lung Inflammation and Use of CDK4/6 Inhibitors

USPSTF Recommendation Updates for Women With BRCA-Related Cancer

Quality Care 2019: Impact of Breast Cancer on Key Support Person’s Employment

Is Red Meat Consumption Linked to Breast Cancer Risk?

Two-Drug Combination Targets Resistance in Cancer

FDA Draft Guidance Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials

Comparing First-Line Treatments in Triple-Negative Breast Cancer

Real-World Data on Palbociclib Plus Endocrine Therapy in Men With Advanced Breast Cancer

IMpassion130 Trial: Atezolizumab Plus Nab-paclitaxel in Advanced Triple-Negative Breast Cancer

Is Soy Intake Related to Bone Fractures for Breast Cancer Survivors?

FDA Requests Manufacturer Recall of Certain Textured Breast Implants

Does Eribulin Mesylate Plus Pembrolizumab Improve Outcomes in Metastatic Breast Cancer?

Communicating With Older Patients About the Need for Breast Cancer Screening

Updated ASCO Clinical Practice Guideline Integrates TAILORx Trial Results in Breast Cancer

NALA Trial: Neratinib Versus Lapatinib Combination Therapy for Metastatic Breast Cancer

De-escalation of Bone-Targeting Agents for Bone Metastases From Breast Cancer

SOPHIA Trial: Adding Margetuximab or Trastuzumab to Chemotherapy in Breast Cancer

Comparing Radiation Regimens in Early-Stage Breast Cancer

Does Environmental Quality Impact the Odds of Developing Aggressive Breast Cancer?

Racial Differences in Risk of Aggressive Breast Cancer After Ductal Carcinoma in Situ

ASCO 2019: Novel Targeted Therapy Active in Metastatic Breast Cancer

ASCO 2019: Final Results of KRISTINE Trial of Neoadjuvant Regimens in HER2-Positive Breast Cancer

New Trastuzumab Biosimilar Approved by the FDA

ASCO 2019: Can Clinical Risk Stratification Predict Chemotherapy Benefit in Early Breast Cancer?

Targeting Mitochondrial Metabolism in Triple-Negative Breast Cancer

ACP Issues New Guidance Statement for Breast Cancer Screening in Average-Risk Women

ASCO 2019: CDK4/6 Inhibitor Plus Endocrine Therapy Improves Overall Survival in Advanced Breast Cancer

Retrospective Update on Nipple-Sparing Mastectomy

U.S. and Canadian Home Recovery Programs After Mastectomy

FDA Approves Alpelisib Combination Therapy for Advanced Breast Cancer

Breast Cancer Treatment Outcomes in Young Women

Effect of Chemotherapy Scheduling on Quality of Life in Advanced Breast Cancer

ARRS 2019: BI-RADS 3 Lesions Identified on High-Risk Screening Breast MRI

ASCO 2019: Can a Low-Fat Diet Reduce Breast Cancer Mortality?

Leronlimab Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer

ESMO Breast 2019: Global Survey of HER2 Testing Shows Room for Improvement

ESMO Breast 2019: Intermittent vs. Continuous Chemotherapy in HER2-Negative Breast Cancer

ASBrS 2019: Some Women With HER2-Positive Breast Cancer May Not Need Surgery

Ado-Trastuzumab Emtansine Granted FDA Approval in HER2-Positive Early Breast Cancer

ESMO Breast 2019: De-escalation Strategy for Women With HER2-Positive Metastatic Breast Cancer

ESTRO 2019: 10-Year Follow-up of Whole-Breast Irradiation in Low-Risk Breast Cancer

Breast Cancer’s Genetic Relationship to Other Cancers

Brain Metastases and Estrogen: Is There a Link in Triple-Negative Breast Cancer?

Canada Halts Sales of Cancer-Linked Breast Implants

INT230-6 Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer

AACR 2019: Primary Tumor Surgery for Advanced HER2-Positive Breast Cancer

AACR 2019: Predicting Breast Cancer Survival With Estrogen Byproducts

HOPA 2019: Does Receptor Expression Affect Efficacy of Talazoparib in Advanced Breast Cancer?

Is There a Link Between Age Acceleration and Breast Cancer Risk?

FDA Extends Indication of Palbociclib Combination to Men With Breast Cancer

Novel Antibody Drug-Conjugate in Metastatic Triple-Negative Breast Cancer